<bill session="117" type="h" number="3808" updated="2022-12-30T17:47:45Z">
  <state datetime="2021-06-11">REFERRED</state>
  <status>
    <introduced datetime="2021-06-11"/>
  </status>
  <introduced datetime="2021-06-11"/>
  <titles>
    <title type="display">Medicare IVIG Access Enhancement Act</title>
    <title type="official" as="introduced">To provide for a demonstration project to further examine the benefits of providing coverage and payment for items and services necessary to administer intravenous immune globulin (IVIG) in the home, and for other purposes.</title>
    <title type="short" as="introduced">Medicare IVIG Access Enhancement Act</title>
  </titles>
  <sponsor bioguide_id="B000574"/>
  <cosponsors>
    <cosponsor bioguide_id="B001251" joined="2021-06-11"/>
    <cosponsor bioguide_id="D000197" joined="2022-01-20"/>
    <cosponsor bioguide_id="F000466" joined="2022-06-28"/>
    <cosponsor bioguide_id="G000559" joined="2021-07-19"/>
    <cosponsor bioguide_id="G000582" joined="2021-06-29"/>
    <cosponsor bioguide_id="K000188" joined="2021-07-26"/>
    <cosponsor bioguide_id="L000589" joined="2022-03-31"/>
    <cosponsor bioguide_id="L000591" joined="2022-01-12"/>
    <cosponsor bioguide_id="M000312" joined="2022-01-12"/>
    <cosponsor bioguide_id="N000002" joined="2021-12-09"/>
    <cosponsor bioguide_id="R000515" joined="2021-12-09"/>
    <cosponsor bioguide_id="S001185" joined="2022-05-13"/>
    <cosponsor bioguide_id="S001172" joined="2021-07-01"/>
    <cosponsor bioguide_id="S000522" joined="2021-06-11"/>
    <cosponsor bioguide_id="W000826" joined="2021-11-16"/>
  </cosponsors>
  <actions>
    <action datetime="2021-06-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-06-11" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-06-11">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-06-11">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-06-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2021-07-23T14:34:49Z" status="Introduced in House">Medicare IVIG Access Enhancement Act

This bill requires the Centers for Medicare &amp; Medicaid Services to establish a five-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.</summary>
</bill>
